FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

FDA Holds Novavax Covid/Flu Vaccine IND

FDA places a clinical hold on the Novavax IND for a Covid-19/influenza combination vaccine and influenza standalone vaccine following a report of one ...

latest-news-card-1
Human Drugs

GDUFA Division Level Reconsideration Request

FDA publishes a guidance reflecting GDUFA 3 provisions on the procedures for ANDA applicants to follow in requesting reconsideration of scientific iss...

latest-news-card-1
Medical Devices

FDA Clears Medical AI Imaging Software

FDA clears a Bracco Diagnostics and Subtle Medical 510(k) for their artificial intelligence-powered software AiMify for brain MRIs.

latest-news-card-1
Human Drugs

Novocures Optune Lua for Lung Cancer OKd

Novocure wins PMA approval for Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or docetaxel for treating adult patients with metastatic non-s...

latest-news-card-1
Human Drugs

Court Tosses Novartis Entresto Suit Against FDA

The DC federal court rules in favor of FDA and MSN Pharmaceuticals as defendants in a suit filed by Novartis over the agencys approval of MSNs generic...

latest-news-card-1
Human Drugs

GSK NDA Accepted for New Antibiotic

FDA accepts for priority review a GSK NDA for gepotidacin, a first-in-class oral antibiotic for treating female adults and adolescents with uncomplica...

latest-news-card-1

FDAs Central Role in AI Regulation

FDA commissioner Robert Califf and two colleagues discuss the agencys role in regulating artificial intelligence in biotechnology and healthcare.

latest-news-card-1
Federal Register

Guidance on Temp Policies for Drug Compounding

Federal Register notice: FDA makes available a final guidance entitled Temporary Policies for Compounding Certain Parenteral Drug Products.

latest-news-card-1
Human Drugs

Jazz Plans sNDA for Zepzelca in Lung Cancer

Jazz Pharmaceuticals plans to file a supplemental NDA next year following positive top-line results from its Phase 3 clinical trial evaluating Zepzelc...

latest-news-card-1
Human Drugs

CDER, CBER Working on START Trial Support Program

CDER director Patrizia Cavazzoni says the Center worked with CBER to launch in 2023 the START program, providing selected participants enhanced commun...